Benefit of lamivudine therapy and factors associated with clinical outcome in spontaneous severe acute exacerbation of chronic hepatitis B virus infection.
about
On-treatment mortality predictors in chronic hepatitis B patients experiencing severe acute exacerbation: a prospective observational studyAnti-viral therapy in hepatitis B virus reactivation with acute-on-chronic liver failure.The effect of plasma exchange on entecavir-treated chronic hepatitis B patients with hepatic de-compensation and acute-on-chronic liver failure.Entecavir and lamivudine therapy for severe acute chronic hepatitis B.Determinants of the clinical outcome of patients with severe acute exacerbation of chronic hepatitis B virus infection.Frequency and clinical outcomes of flares related to nucleos(t)ide analogue therapy in patients with chronic hepatitis B
P2860
Benefit of lamivudine therapy and factors associated with clinical outcome in spontaneous severe acute exacerbation of chronic hepatitis B virus infection.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Benefit of lamivudine therapy ...... c hepatitis B virus infection.
@en
Benefit of lamivudine therapy ...... c hepatitis B virus infection.
@nl
type
label
Benefit of lamivudine therapy ...... c hepatitis B virus infection.
@en
Benefit of lamivudine therapy ...... c hepatitis B virus infection.
@nl
prefLabel
Benefit of lamivudine therapy ...... c hepatitis B virus infection.
@en
Benefit of lamivudine therapy ...... c hepatitis B virus infection.
@nl
P2093
P2860
P356
P1433
P1476
Benefit of lamivudine therapy ...... c hepatitis B virus infection.
@en
P2093
Akihito Tsubota
Fumitaka Suzuki
Hiromitsu Kumada
Kenji Ikeda
Masahiro Kobayashi
Norio Akuta
Satoshi Saitoh
Takashi Someya
Tetsuya Hosaka
Yasuji Arase
P2860
P304
P356
10.1159/000080877
P577
2004-11-01T00:00:00Z